Queen of TERF Island, Joanne Rowling, has a brain affected by the black mold in her lofty castle. Poor thing.
Fact Check: New York Times Publishes Misleading Story On Puberty Blocker Study
Fact Check: New York Times Publishes Misleading Story On Puberty Blocker Study
Quote:In recent weeks, several studies have emerged focusing on transgender individuals. One study in the prestigious journal Nature Human Behavior, for example, reported up to a 72% increase in suicide attempts in states passing anti-trans legislation, including healthcare bans. Another study, with minimal loss to follow-up, found extremely low detransition rates among transgender youth over 6 to 10 years, along with high levels of satisfaction regarding their care. Yet, you won’t find these stories on The New York Times' website. Instead, as has become routine at the paper, there’s yet another hit piece on transgender care—one that, upon closer inspection, offers a distorted and unfounded portrayal of the current research and one researcher who has helped push that research forward.
The latest piece, which went viral in anti-trans circles on Wednesday, was written by Azeen Ghorayshi, who has a track record of publishing anti-trans articles, including a glowing profile of Jamie Reed, an anti-trans clinician who shared private information about patients at her clinic—some of which was later proven false. This new article makes explosive claims that Dr. Johanna Olson-Kennedy, a prominent gender researcher, is withholding potentially negative research on the risks and benefits of puberty blockers for transgender youth.
A further analysis of the article finds the central premise to be highly misleading.
Claim: Joana Olson-Kennedy is withholding research from the Trans Youth Care because of a charged American political environment over transgender people.
Fact: Twenty-eight studies have been published from the Trans Youth Care (TYC) Network study, including from patients on puberty blockers.
“An influential doctor and advocate of adolescent gender treatments said she had not published a long-awaited study of puberty-blocking drugs because of the charged American political environment.”
Ghorayshi opens with a claim that Olson-Kennedy is withholding research on puberty blockers because of a “charged American political environment.” The research in question comes from the Transgender Youth Care (TYC) Network study, funded by the National Institutes of Health to evaluate the effectiveness of gender-affirming care for transgender youth. In her interview with Olson-Kennedy, Ghorayshi cites a quote from what was described as a “wide-ranging interview” on the researcher’s work. Olson-Kennedy explains that she is being meticulous with one of the registered studies on puberty blockers because she doesn’t want her findings “to be weaponized,” adding that the work “has to be exactly on point, clear and concise.” Ghorayshi then uses this quote to imply that Olson-Kennedy is withholding research for political reasons.
A closer look at the NIH-funded project’s research record shows that the team’s output has been extraordinarily prolific; if Olson-Kennedy is withholding research, her extensive publication history doesn’t reflect it. The project has resulted in 28 peer-reviewed papers, many with Olson-Kennedy as a co-author. These studies include those who are on puberty blockers, such as one on the height growth rate of transgender youth on puberty blockers, another comparing the effectiveness of puberty blocker implants, and a third showing that patients who presented for puberty blockers had better mental health than those who either waited, or were forced to wait, for hormone therapy. This is in addition to numerous influential studies the team has published on the positive effects of hormone therapy and other key characteristics of transgender youth.
Knowledge is knowing that a tomato is a fruit. Wisdom is not putting it in a fruit salad.